PT  - JOURNAL ARTICLE
AU  - Aleti, Gajender
AU  - Kohn, Jordan N.
AU  - Troyer, Emily A.
AU  - Weldon, Kelly
AU  - Huang, Shi
AU  - Tripathi, Anupriya
AU  - Dorrestein, Pieter C.
AU  - Swafford, Austin D.
AU  - Knight, Rob
AU  - Hong, Suzi
TI  - Salivary bacterial signatures in depression-obesity comorbidity are associated with neurotransmitters and neuroactive dipeptides
AID  - 10.1101/2021.08.10.21255754
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.08.10.21255754
4099  - http://medrxiv.org/content/early/2021/08/12/2021.08.10.21255754.short
4100  - http://medrxiv.org/content/early/2021/08/12/2021.08.10.21255754.full
AB  - Background Depression and obesity, both of which are highly prevalent and inflammation underlies, often co- occur. Microbiome perturbations are implicated in obesity-inflammation-depression interrelationships, but how microbiome alterations contribute to underlying pathologic processes remains unclear. Metabolomic investigations to uncover microbial neuroactive metabolites may offer mechanistic insights into host-microbe interactions.Methods Using 16S sequencing and untargeted mass spectrometry of saliva, and blood monocyte inflammation regulation assays, we determined key microbes, metabolites and host inflammation in association with depressive symptomatology, obesity, and depressive symptomatology-obesity comorbidity.Results Gram-negative bacteria with inflammation potential were enriched relative to Gram-positive bacteria in comorbid obesity-depression, supporting the inflammation-oral microbiome link in obesity-depression interrelationships. Oral microbiome was highly predictive of depressive symptomatology-obesity co-occurrences than obesity and depressive symptomatology independently, suggesting specific microbial signatures associated with obesity-depression co- occurrences. Mass spectrometry analysis revealed significant changes in levels of signaling molecules of microbiota, microbial or dietary derived signaling peptides and aromatic amino acids among host phenotypes. Furthermore, integration of the microbiome and metabolomics data revealed that key oral microbes, many previously shown to have neuroactive potential, co- occurred with potential neuropeptides and biosynthetic precursors of the neurotransmitters dopamine, epinephrine and serotonin.Conclusions Together, our findings offer novel insights into oral microbial-brain connection and potential neuroactive metabolites involved.Competing Interest StatementPCD serves as a scientific advisor to Sirenas, Cybele and Galileo. PCD is also a founder and scientific advisor of Ometa and Enveda with approval by UC San Diego.Funding StatementThis work was supported in part by R01 HL90975 and 90975S1 from the NIH (Hong), a Seed Grant from the Center for Microbiome Innovation at UC San Diego (Hong), Wayne State University Endowment Fund (Hong), and the Kavli Institute for Brain and Mind (KIBM) Innovative Research Grant (Aleti).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants provided informed consent to the protocol prior to the commencement of the study. The Ethics Committee of the University of California, San Diego, CA, USA, approved the study design as well as the procedure for obtaining informed consent (IRB reference number: 171027). All experiments were performed in accordance with the approved guidelines of UCSD Human Research Protections Program.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSample metadata, the raw and processed 16S sequencing data and their associated feature tables, and preparation metadata are available in Qiita Study ID 11259 (https://qiita.ucsd.edu/study/description/11259). Mass spectral files and LC-MS/MS preparation metadata are accessible from the MassIVE repository accession ID MSV000083077 (ftp://massive.ucsd.edu/MSV000083077). The GNPS feature based molecular networking job is available at https://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=f192a0030f694224a0ba8f08223a1323 https://qiita.ucsd.edu/study/description/11259 ftp://massive.ucsd.edu/MSV000083077 https://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=f192a0030f694224a0ba8f08223a1323